Background: Hyperactivation of mechanistic target of rapamycin (mTOR) signaling pathway is involved in the regulation of cellular growth, proliferation, and more in general, is a common phenomenon in most types of cancers. Thus, natural substances targeting this pathway can be of great therapeutic potential in supporting the treatment of tumor patients. Rhus tripartita (Ucria) Grande is a plant growing in desertic areas which is traditionally used for the treatment of several diseases in Tunisia. In the present work, the biochemical profile of the main compounds present in the plant leaf extract was determined and the anti-leukemic potential of the plant extracts against acute monocytic leukaemia (AML) THP-1 cells was investigated. Methods: After HPLC identification of some phenolic compounds present in the plant extract and the quantification of saponin content, the cytotoxic effect of Rhus tripartita extracts on THP-1 cell culture was evaluated using the colorimetric MTT assay for cell viability. THP-1 cells were incubated with medium containing the relative IC₅₀ concentrations of total plant extract, saponin extract and some standard compounds (rutin (R); kaempferol (K); mixture of catechin, epicatechin, and epicatechin-gallate (CEEG); ellagic acid (EA). Finally, qRT-PCR and western blotting analysis were used to evaluate the effect of some flavonoids present in a crude extract of polyphenols and the total extract of saponins on cell survival and apoptosis. Results: Analysis of expression level of some gene (PIK3CA, PTEN, AKT1, mTOR, EIF4E, RPS6KB1, and TSC1) involved in the mTOR pathway and the phosphorylation of S6 and AKT proteins allowed to observe that a total Rhus tripartita extract and some of the compounds found in the extract controls THP-1 cell proliferation and apoptosis via regulation of the PI3K-Akt-mTOR signaling pathway. Conclusion: Rhus tripartita-induced inhibition of cell cycle and induction of apoptosis may involve the mTOR pathway. Therefore, Rhus tripartita extract may be a useful candidate as a natural anti-cancer drug to support the treatment of AML.

Brassica tournefortii Gouan, commonly known (Aslooz) in Tunisia, is an annual plant, native to the North Africa and Middle East. Brassica species are used as food, their young leaves can be cooked, providing nutrients and health-giving phytochemicals such as phenolic compounds, polyphenols and carotenoids. Phytochemical composition and bioactivity of Brassica tournefortii leaf extracts, collected from four different bioclimatic zones in Tunisia, are investigated in the present study. Results showed that location and climatic variations can alter the phytochemical composition of B. tournefortii. Interestingly, HPLC analysis enabled identifying lutein and beta-carotene at high concentrations, especially in extracts of B. tournefortii collected from Gabes (B2) (344 µg/g of lutein) and B. tournefortii collected from Zarzis (B3) (1364 µg/g of beta-carotene). In particular, the antioxidant activity measured by DPPH assay showed that the extract of the plants collected from the growing region of Zarzis exhibits the highest antioxidant activities (0.99 mg/mL). All the Brassica tournefortii extracts showed a relevant antiproliferative activity, especially toward the Caco-2 cell line. These preliminary data resulted in being useful to correlate growth environmental conditions with different accumulation of metabolites in Brassica species still being poorly studied.